Evidence map›Paper›PMID 41896199›Full record

ArticleCell death & disease2026

LMO7-mediated POLR2A degradation promotes cellular senescence through the MDM4/p53/p21 axis.

Chutong Lai, Wen Fu, Jiaxin Liu, Shuai Hou, Jinsong Yan, Haixin Lei

Abstract read
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chutong LaiInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, PR China.
Wen FuInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, PR China.
Jiaxin LiuInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, PR China.
Shuai HouInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, PR China. houshuai@dmu.edu.cn.ORCID http://orcid.org/0000-0001-5274-5264
Jinsong YanDepartment of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Trans-plantation, The Second Hospital of Dalian Medical University, Dalian, PR China. yanjsdmu@dmu.edu.cn.ORCID http://orcid.org/0000-0003-4109-2602
Haixin LeiInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, PR China. haixinlei@dmu.edu.cn.ORCID http://orcid.org/0000-0003-2445-8131

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the largest subunit of RNA polymerase II, POLR2A plays an irreplaceable role in gene expression, with the regulation of its own expression and physiological function having attracted widespread attention. Here we report POLR2A as a critical guardian against cellular senescence. A significant decline in POLR2A expression was observed in senescent cells and certain tissues of aging mice. Whereas its depletion dramatically induced cellular senescence, conversely, activating endogenous POLR2A expression in senescent cells using CRISPRa technology alleviated the senescent phenotype. We further demonstrated that POLR2A-induced senescence is p53-dependent, as evidenced by the activation of the p53/p21 pathway upon POLR2A knockdown and the rescue of the senescence phenotype following co-depletion of POLR2A and p53. Bioinformatic analysis on RNA-seq data from POLR2A depletion and replicative senescent cells led to the identification of MDM4 as the key mediator of p53 upregulation following POLR2A knockdown. Most intriguingly, immunoprecipitation assay further revealed that the E3 ligase LMO7 was recruited to POLR2A to promote the ubiquitination and proteasomal degradation of POLR2A under cellular senescence. Depletion of LMO7 abolished the ubiquitination and reduction of POLR2A in H₂O₂-induced senescent cells. Taken together, we concluded that the LMO7-induced POLR2A degradation drived cellular senescence through the MDM4/p53/p21 axis.

Indexed as

Cell Cycle ProteinsCellular SenescenceCyclin-Dependent Kinase Inhibitor p21DNA-Directed RNA PolymerasesLIM Domain ProteinsProto-Oncogene ProteinsRNA Polymerase IITranscription FactorsTumor Suppressor Protein p53AnimalsHumansMiceProteolysisSignal TransductionUbiquitinationCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p21DNA-Directed RNA PolymerasesLIM Domain ProteinsPOLR2A RNA polymerase, humanProto-Oncogene ProteinsRNA Polymerase IITranscription FactorsTumor Suppressor Protein p53

Identifiers

PMID41896199
PMCPMC13149549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.